<qa>  What was a feasibility study aimed at elevating PI dosage as part of active antiThis was a feasibility study aimed at elevating protease inhibitors PI dosage as a part of active antiretroviral therapy HAART. After the pharmacokinetics for the currently prescribed PI were determined,patients with a vIQ1 were eligible for a 50 dose increase for an 8 week time frame after which their vIQ would be reassessed to determine if increasing their PI dosage thereby increasing the bioavaiability would reduce their viral load. 